Views and practices of community pharmacists regarding services for people with type 2 diabetes

International Journal of Pharmacy Practice

Volumn 11, Issue 3, 2003, Pages 161-168

  Abduelkarem, Abduelmula R ^a   Sackville, Mike A ^b   Morgan, Rae M ^b   Sackville, Margaret P ^b   Hildreth, Anthony J ^c  

^a AJMAN UNIVERSITY   (United Arab Emirates)

^b UNIVERSITY OF SUNDERLAND   (United Kingdom)

^c SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; CIGARETTE SMOKING; CLINICAL PRACTICE; DIABETES MELLITUS; DIABETIC RETINOPATHY; ETHNIC GROUP; GLUCOSE BLOOD LEVEL; HEALTH PROMOTION; HEALTH SERVICE; HOME CARE; HUMAN; LIFESTYLE; MOSLEM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PATIENT COUNSELING; PATIENT MONITORING; PHARMACIST; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SMOKING CESSATION; UNITED KINGDOM;

EID: 0141569932     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357021990     Document Type: Review

References (47)

1. Weinberger M, Kirkman S, Samsa GP, Shortilffe EA, Cowper PA, Simel DL, et al. The relationship between glycaemic control and health related quality of life in-patients with Non-Insulin-Dependent Diabetes Mellitus. Med Care 1994;32:1173-81.
2. Manson JE, Ajani UA, Liu S, Nathan DM, Hennekens CH. A prospective study of cigarette smoking and the incidence of diabetes mellitus among US male physicians. Am J Med 2000;109:538-42.
3. The management of type 2 diabetes - a practical guide for pharmacists. SmithKline Beecham; 2000.
4. Coster S, Gulliford MC, Seed PT, Powrie JK, Swaminathan R. Monitoring blood glucose control in diabetes mellitus: a systematic review. Health Tech Assess 2000;4:1-72.
5. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabet Med 1997;14:S7-S15.
6. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991;337:382-6.
7. Raleigh VS, Kiri V, Balarajan R. Variations in mortality from diabetes mellitus, hypertension and renal disease in England and Wales by country of birth. Health Trends 1996;28:122-7.
8. Hegele RA, Hanley AJG, Zinman B, Harris SB, Anderson CM. Youth-onset type 2 diabetes (Y2DM) associated with HNF1A S319 in aboriginal Canadians. Diabetes Care 1999;22:2095-6.
9. Ehtisham S, Barrett TG, Shaw NJ. Type 2 diabetes mellitus in UK children - an emerging problem. Diabet Med 2000;17:867-71.
10. Nielsen JV. Diabetes in the Arab world: prevalence and risk factors. Pract Diabetes Int 1999;16:82-6.
11. Anderson S. The historical context of pharmacy. In: Taylor K, Harding G, editors. Pharmacy Practice. London: Taylor & Francis; 2001. p4-30.
12. Farris KB, Kirking DM. Assessing the quality of pharmaceutical care: II. Application of concepts of quality assessment from medical care. Ann Pharmacother 1993;27:215-22.
13. Kielgast PJ. The 21st-century pharmacist! Int Pharm 1997;11:30.
14. Pharmacy in the future - implementing the NHS Plan. A programme for pharmacy in the National Health Service. London: Department of Health; 2000.
15. Galanti GA. Caring for Muslim patients [book review]. BMJ 2001;322:242.
16. Aslam M, Jessa F, Wilson J. Ethnic minorities. In: Taylor, K, Harding G, editors. Pharmacy Practice. London: Taylor & Francis; 2001. p274-87.
17. Coast-Senior EA, Kroner BA, Kelley CL, Trilli LE. Management of patients with type 2 diabetes by pharmacist in primary care clinics. Ann Pharmacother 1998;32:636-41.
18. Douglas E, Hudson S, Bennie M, McGbee D, Dowers A, McShane C. Pharmaceutical care needs in the primary care management of type 2 diabetes mellitus. Pharm J 2000;265 Suppl:R6.
19. Munroe WP, Kunz K, Dalmady C, Potter L, Schonfeld WH. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther 1997;19:113-23.
20. Pickard AS, Johnson JA, Farris K. The impact of pharmacist interventions on health-related quality of life. Ann Pharmacother 1999;33:1167-72.
21. Younis WS, Campbell S, Slack MK. Pharmacists' attitudes toward diabetes and their involvement in diabetes education. Ann Pharmacother 2001;35:841-5.
22. Schapansky LM, Johnson JA. Pharmacists' attitudes toward diabetes. J Am Pharm Assoc 2000;40:371-7.
23. Jesson J, Pocock R. Survey methods. In: Taylor K, Harding G, editors. Pharmacy practice. London: Taylor & Francis; 2001. p434-55.
24. Smith F. Survey research: (1) Design, samples and response. Int J Pharm Pract 1997;5:152-66.
25. Department of Health. National Service Framework: Diabetes. Available at www.doh.gov.uk./nsf/diabetes (accessed 18 February 2003).
26. Diabetes Task Force: Practice guidance for community pharmacists on the care of people with diabetes. London: Royal Pharmaceutical Society of Great Britain; 2001.
27. Hargie O, Morrow N, Woodman C. Consumer perceptions of and attitudes to community pharmacy services. Pharm J 1992;249:688-91.
28. Gupchup GV, Wolfgangm AP, Thomas III J. Development of a scale to ensure directive guidance by pharmacist. Ann Pharmacother 1996;30:1369-75.
29. Bleiker P, Lewis A. Extending the role of community pharmacists: the views of GPs. Int J Pharm Pract 1998;6:140-4.
30. Smith F. Survey research: (2) Survey instruments, reliability and validity. Int J Pharm Pract 1997;5:216-26.
31. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill; 1998.
32. Hepler CD. Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;533:533-43.
33. Van Mil JWF, De Boer WO, Tromp ThFJ. European barriers to the implementation of pharmaceutical care. Int J Pharm Pract 2001;9:163-8.
34. Rees PA. Counselling and pharmacists. Pharm J 1996;257:659.
35. Goldstein R. The elderly and their carers. In: Taylor K, Harding G, editors. Pharmacy practice. London: Taylor & Francis; 2001. p314-27.
36. Blenkinsopp A, Anderson C, Panton R. Promoting health. In: Taylor K, Harding G, editors. Pharmacy practice. London: Taylor & Francis; 2001. p152-64.
37. Morrow N, Hargie W. Communication skills and health promotion. Pharm J 1994;253:311-3.
38. Maguire T. Health promotion and the pharmacist. Pharm J 1996;257:744.
39. Hargie OD, Morrow NC, Woodman C. Pharmacists' evaluation of key communication skills in practice. Patient Educ Couns 2000;39:61-70.
40. Kotecki JE, Elanjian SI, Torabi MR. Health promotion beliefs and practices among pharmacists. J Am Pharm Assoc 2000;40:773-9.
41. Blyth R. The Nuffield report - catalyst of change. Pharm J 1995;255:586-90.
42. Oparah CA, Iwuagwu MA. Public perceptions of community pharmacists in Benin city, Nigeria. Int J Pharm Pract 2001;9:191-5.
43. McClean MT, McElnay JC, Andrews J. The importance of patient education and patient involvement in the treatment of diabetes. Pharm J 2000;265 Suppl:R20.
44. Dickinson D, Wilkie P, Harris M. Taking medicines: concordance is not compliance [letter]. BMJ 1999;319:787.
45. Misselbrook D. Managing the change from compliance to concordance. Prescriber 1998;9(April 19):23-33.
46. Smeeth L, Fletcher AE, Stirling S, Nunes M, Breeze E, Bulpitt CJ, et al. Randomised comparison of three methods of administering a screening questionnaire to elderly people: finding from the MRC trial of the assessment and management of older people in the community. BMJ 2001;323:1403-7.
47. Edwards P, Roberts I, Clarke M, DiGuiseppi C, Pratap S, Wentz R, et al. Increasing response rates to postal questionnaires: systematic review. BMJ 2002;324:1183-5.